CTR UTSW ODL Brain Inst Admin

Medicine & Life Sciences

1. Dystonia 100%
2. Neurodevelopmental Disorders 44%
3. Nuclear Envelope 42%
4. Varenicline 41%
5. Cholinergic Receptors 31%
6. Nicotinic Receptors 31%
7. Non-alcoholic Fatty Liver Disease 30%
8. Phenotype 28%
9. Parkinson Disease 23%
10. Loss of Function Mutation 21%
11. Dyskinesias 20%
12. Nervous System 19%
13. Peptides 18%
14. Genetic Therapy 17%
15. Hepatocytes 15%
16. Liver 14%
17. ATPases Associated with Diverse Cellular Activities 14%
18. Gait 13%
19. Nervous System Diseases 13%
20. Lipids 12%
21. Walking Speed 12%
22. Therapeutics 11%
23. Movement Disorders 10%
24. Fatty Liver 10%
25. Nuclear Proteins 9%
26. Cross-Over Studies 9%
27. Lipid Metabolism 9%
28. Organelles 9%
29. Embryonic Development 8%
30. Mutation 7%
31. Membrane Proteins 7%
32. fluoroethoxy-benzovesamicol 7%
33. Insulin Resistance 7%
34. fluoronorchloroepibatidine 7%
35. Genes 7%
36. Alleles 6%
37. Cholinergic Agents 6%
38. Positron-Emission Tomography 6%
39. Obesity 6%
40. Diet 6%
41. Brain 6%